Understand how pharmaceutical and biotechnology companies share development responsibilities, investment and opportunity using intelligence from 1,069 real-world co-development deals.
Co-development Deals in Pharmaceuticals and Biotechnology 2016-2026 provides comprehensive intelligence on 1,069 co-development deals across the global life sciences industry.
Co-development partnerships enable companies to combine assets, expertise, technology and funding to advance products through development while sharing responsibilities, costs, risk and potential future value.
These arrangements can vary substantially. Partners may divide research and development activities, share development expenditure, allocate regulatory responsibilities, retain different geographic or commercial rights and agree financial structures that reflect their respective contributions.
The report brings this activity together in one resource, enabling users to understand who is entering co-development partnerships, how responsibilities and rights are allocated, which companies are most active, what financial terms have been disclosed and how comparable agreements have been structured in practice.
Rather than simply identifying transactions, the report combines market-wide deal analysis with agreement-structure intelligence, leading dealmaker profiles, financial information, detailed transaction records and access to publicly available contract documents where available.
It provides a practical intelligence and benchmarking resource for business development, licensing, R&D strategy, portfolio strategy, alliance management, finance and legal teams involved in evaluating, structuring or negotiating co-development partnerships.
This provides useful precedent intelligence for internal benchmarking, deal preparation and negotiation without relying on headline values in isolation.
Identify prospective co-development partners, comparable transactions and relevant deal structures.
R&D and Development Strategy teams
Understand how companies share development activities, costs, capabilities and responsibilities.
Portfolio and Corporate Strategy teams
Evaluate co-development as an alternative to wholly internal development, licensing or other partnering approaches.
Companies Seeking Development Partners
Identify organizations with demonstrated experience in relevant technologies, therapy areas and stages of development.
Alliance Management teams
Examine how governance, responsibilities and continuing obligations have been structured across comparable partnerships.
Finance and Transaction teams
Investigate disclosed funding, cost-sharing and other economic arrangements within precedent transactions.
Competitive and Market Intelligence teams
Track how competitors are using co-development to advance assets and access external capabilities.
Legal teams
Review publicly available agreements and precedent structures to support transaction preparation and negotiation.
The briefing applies the underlying co-development deal intelligence to the customer's own asset, technology, development program or partnering objectives.
Depending on requirements, this can include relevant comparable transactions, prospective development partners, competitor activity, development-stage analysis, agreement structures, financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
Co-development Deals in Pharmaceuticals and Biotechnology 2016-2026 provides comprehensive intelligence on 1,069 co-development deals across the global life sciences industry.
Co-development partnerships enable companies to combine assets, expertise, technology and funding to advance products through development while sharing responsibilities, costs, risk and potential future value.
These arrangements can vary substantially. Partners may divide research and development activities, share development expenditure, allocate regulatory responsibilities, retain different geographic or commercial rights and agree financial structures that reflect their respective contributions.
The report brings this activity together in one resource, enabling users to understand who is entering co-development partnerships, how responsibilities and rights are allocated, which companies are most active, what financial terms have been disclosed and how comparable agreements have been structured in practice.
Rather than simply identifying transactions, the report combines market-wide deal analysis with agreement-structure intelligence, leading dealmaker profiles, financial information, detailed transaction records and access to publicly available contract documents where available.
It provides a practical intelligence and benchmarking resource for business development, licensing, R&D strategy, portfolio strategy, alliance management, finance and legal teams involved in evaluating, structuring or negotiating co-development partnerships.
Understand the co-development deal landscape
The report analyzes co-development dealmaking from 2016 to 2026, including:
- Trends in co-development activity by year
- Phase of development at the time of partnering
- Industry sector
- Therapy area
- Technology type
- Most active co-development dealmakers
- Leading transactions by disclosed value
- Reasons companies enter co-development partnerships
- How co-development strategies are evolving
Understand how co-development agreements are structured
Co-development partnerships require clear allocation of responsibilities, investment, decision-making and future rights between the parties.Depending on the transaction and available disclosure, users can investigate areas including:
- Research and development responsibilities
- Development cost sharing
- Funding commitments
- Intellectual property ownership and licensing
- Governance and decision-making
- Development plans and responsibilities
- Regulatory obligations
- Manufacturing and supply
- Geographic and territorial rights
- Commercialization responsibilities
- Rights retained by each partner
- Milestones, royalties and other financial consideration
- Term and termination provisions
Benchmark leading deals and disclosed financial terms
The report identifies leading co-development transactions by disclosed value and provides access to available financial information associated with individual agreements.Depending on the transaction, users can investigate elements including:
- Upfront payments
- Development funding
- Cost-sharing arrangements
- Milestone payments
- Equity contributions
- Royalty arrangements
- Other disclosed financial commitments
This provides useful precedent intelligence for internal benchmarking, deal preparation and negotiation without relying on headline values in isolation.
Identify leading co-development dealmakers and prospective partners
The report identifies the Top 25 most active co-development dealmakers and provides transaction histories that enable users to investigate their previous activity.This can help users identify:
- Companies actively seeking co-development opportunities
- Prospective development partners
- Organizations repeatedly active in particular therapy or technology areas
- Companies prepared to share development investment and responsibility
- Dealmakers active at relevant stages of development
- Competitors pursuing similar external development strategies
- Relevant precedent transactions
Assess co-development as a partnering strategy
Co-development occupies a distinctive position between conventional licensing and wholly internal development.It can allow partners to:
- Share development costs and risk
- Combine complementary development capabilities
- Retain greater involvement in an asset
- Access expertise or infrastructure not available internally
- Share future commercial opportunity
- Maintain strategic influence over development
- Advance programs that may be difficult for one party to progress alone
Learn from real-world co-development contracts
Where publicly available, the report provides access to underlying contract documents for selected co-development transactions.These agreements can provide considerably more detail than transaction announcements alone, enabling users to examine how companies have documented matters including:
- Development responsibilities
- Cost sharing and funding
- Intellectual property
- Governance and decision-making
- Regulatory obligations
- Commercial rights
- Milestones and royalties
- Manufacturing and supply
- Termination and continuing rights
Comprehensive co-development deal directory
The report includes a comprehensive directory of 1,069 co-development deals, providing an extensive resource for identifying relevant precedent transactions and prospective partners.Deals can be investigated by:
- Company
- Therapy area
- Technology type
- Contract availability
Who should use this report?
Business Development and Licensing teamsIdentify prospective co-development partners, comparable transactions and relevant deal structures.
R&D and Development Strategy teams
Understand how companies share development activities, costs, capabilities and responsibilities.
Portfolio and Corporate Strategy teams
Evaluate co-development as an alternative to wholly internal development, licensing or other partnering approaches.
Companies Seeking Development Partners
Identify organizations with demonstrated experience in relevant technologies, therapy areas and stages of development.
Alliance Management teams
Examine how governance, responsibilities and continuing obligations have been structured across comparable partnerships.
Finance and Transaction teams
Investigate disclosed funding, cost-sharing and other economic arrangements within precedent transactions.
Competitive and Market Intelligence teams
Track how competitors are using co-development to advance assets and access external capabilities.
Legal teams
Review publicly available agreements and precedent structures to support transaction preparation and negotiation.
Turn market-wide co-development intelligence into company-specific insight
For qualifying customers, the analyst can also provide a Customized Executive Partnering Briefing alongside the report.The briefing applies the underlying co-development deal intelligence to the customer's own asset, technology, development program or partnering objectives.
Depending on requirements, this can include relevant comparable transactions, prospective development partners, competitor activity, development-stage analysis, agreement structures, financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
Table of Contents
Executive SummaryChapter 1 - Introduction
Chapter 2 - Trends in co-development dealmaking
Chapter 3 - Overview of co-development deal structure
Chapter 4 - Leading co-development deals
Chapter 5 - Top 25 most active co-development dealmakers
Chapter 6 - Co-development deals including contracts directory
Deal directory
TABLE OF FIGURES
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 1Cell.Ai
- 1ST Biotherapeutics
- 2seventy bio
- 3B Pharmaceuticals
- 3D-Micromac
- 3DMed
- 3D Systems
- 4basebio Discovery
- 4D Molecular Therapeutics
- 10X Genomics
- A*STAR Institute of Microelectronics (IME)
- A2A Pharmaceuticals
- AAK
- Abbisko Therapeutics
- Abbott Laboratories
- Abbvie
- Abcam
- AbCellera Biologics
- AbelZeta Pharma
- Abera Bioscience
- Abingworth Life Sciences
- Abiosciences
- ABL Bio
- ABL Diagnostics
- Abpro
- AbTherx
- AbTis
- AbVacc
- ABVC BioPharma
- Abzena
- ACADIA Pharmaceuticals
- Accelerated Biosciences
- Accelerate Technologies
- Acceleron Pharma
- Accellix
- Accent Therapeutics
- Access Vascular
- Accord Healthcare
- AccuGenomics
- AccurKardia
- AccuStem Sciences
- ACEA Biosciences
- Acepodia
- Ache
- AC Immune
- Aclipse Therapeutics
- Acoustic MedSystems
- Acrivon Therapeutics
- Acuitas Therapeutics
- Acumen Pharmaceuticals
- Adaptimmune
- Adial Pharmaceuticals
- Aduro BioTech
- Adva Biotechnology
- Advaxis
- Adventist Health
- Adventus Ventures
- ADx NeuroSciences
- Aerolase
- Affibody
- Affini-T Therapeutics
- AFT Pharmaceuticals
- AGC Biologics
- Agena Bioscience
- Agendia
- Agenus Bio
- Agilent Technologies
- Agios Pharmaceuticals
- Aignostics
- AIkido Pharma
- AiLife Diagnostics
- AimedBio
- Ainos
- Air Products
- Aitia
- Ajinomoto
- Akcea Therapeutics
- Akoya Biosciences
- Akston Biosciences
- Alamar Biosciences
- Albany Molecular Research
- Alcove Manufacturing and Distribution
- Aldena Therapeutics
- Aldevron
- Alector
- Alexion Pharmaceuticals
- Algen Biotechnologies
- Algenex
- Aliada Therapeutics
- Alibaba Health
- Align Technology
- AliveCor
- Alkem Laboratories
- Allegheny Technologies
- Allele Biotechnology and Pharmaceuticals
- Alligator Bioscience
- Allotex
- Alloy Therapeutics
- Alnylam Pharmaceuticals
- Alopexx
- Alphamab Biopharmaceuticals
- Alteogen
- Alternavida
- Altor BioScience
- Altos Group
- Alveo Technologies
- Alvotech
- Alytas Therapeutics
- Alzheimer's Drug Discovery Foundation
- ALZpath
- Amazon Web Services
- Amerimmune
- Amgen
- Amplifire
- Amyris
- Analog Devices
- Anavex Life Sciences
- AnchorDx
- Andon
- Angelini Pharma
- AnGes MG
- AnHeart Therapeutics
- Anixa Biosciences
- Ankarys Therapeutics
- Anthropic
- Anumana
- Apellis Pharmaceuticals
- Apmonia Therapeutics
- Apobiologix
- Apollomics
- Applied DNA Sciences
- Applied StemCell
- Aprecia Pharmaceuticals
- Aptar Pharma
- Aptevo Therapeutics
- Aptorum Group
- Aptose Biosciences
- Aquestive Therapeutics
- Araceli Biosciences
- ARaymondlife
- Arbele
- Arbor Biotechnologies
- Arbutus
- Arcellx
- Arcturus Therapeutics
- Arcus Biosciences
- Ardeagen
- Arecor
- Arecor Therapeutics
- Argonaut Manufacturing Services
- Armatus Bio
- Arrowhead Pharmaceuticals
- ARTBIO
- Artes Biotechnology
- Arvinas
- Arzeda
- Asahi Kasei
- Ascendis Pharma
- Ascenion
- Ascensia Diabetes Care
- Ascentage Pharma
- ASC Therapeutics
- Asensus Surgical
- ASKA Pharmaceuticals
- Aspect Biosystems
- Aspen Imaging Healthcare
- Astellas Pharma
- AstraZeneca
- Athena Pharmaceutiques
- Atomwise
- Atropos Therapeutics
- Augmenta
- AUM Biosciences
- Aurealis Therapeutics
- Autolomous
- Autotelic BIO
- Avacta
- Avactis Biosciences
- Avalon GloboCare
- Avantor
- Avata Biosciences
- Avellino Labs
- AVEO Oncology
- Avicanna
- Aviragen Therapeutics
- Aviva Systems Biology
- Axela
- AXIM Biotechnologies
- Axio BioPharma
- Axis Lighting
- Axolabs
- Azenta Life Sciences
- Azitra
- Azos Bio
- Bach Biosciences
- Banyan Biomarkers
- Battelle
- Bayer
- B Braun
- Beam Therapeutics
- Beckman Coulter
- Becton Dickinson
- BehaVR
- BeiGene
- Beijing Defengrei Biotechnology
- Beijing Sun-Novo Pharmaceutical Research
- Belharra Therapeutics
- Berry Genomics
- Berry Oncology
- Betta Pharmaceuticals
- Beyondspring Pharmaceuticals
- BGI Americas
- Bharat Biotech
- Biedermann Motech
- BigHat Biosciences
- Bill and Melinda Gates Foundation
- Bilthoven Biologicals
- Bio-Rad Laboratories
- Bio-Techne
- BioAtla
- BioCanna Healthcare
- BioCardia
- Biocare Medical
- BioCentriq
- Biocept
- BioComo
- BIOCORP
- BiocurePharm
- Biocytogen
- Biodesix
- Biodextris
- Bioelectronica
- Biofidelity
- BioGemex
- Biogen
- BIOHM Health Inc
- BioInvent
- BioKey
- BioLabs
- Biolase
- BioLegend
- BiolineRX
- BioMap
- Biomedical Advanced Research and Development Authority
- BIOMEDX Group
- BioMotiv
- Biomunex Pharmaceuticals
- BioNano Genomics
- BioNova Pharmaceuticals
- Bionpharma
- BioNTech
- BioNxt Solutions
- BiosanaPharma
- BioSerenity
- Biosero
- BioSun Pharmed
- BioVaxys
- BioVectra
- Bioventus
- BioVersys
- Bird Foundation
- Blackrock Microsystems
- Blake Insomnia Therapeutics
- Blau Pharma
- Blood Centers of America
- Bloomios
- Blueberries Medical
- Bluebird Bio
- Blueprint Medicines
- Blue Water Vaccines
- BlueWhale Bio
- BodyLogicMD
- Boehringer Ingelheim
- Bolt Biotherapeutics
- Boost Biomes
- Boreal Genomics
- Boryung Pharmaceutical
- Boston Scientific
- BrainLAB
- BreathTech
- BrickBio
- BridgeBio Pharma
- Bridge Biotherapeutics
- Brigham and Women's Hospital
- BrighGene Biomedical
- Bristol-Myers Squibb
- Broad Clinical Labs
- Broad Institute
- Bruker
- Bruker Energy & Supercon Technologies (BEST)
- Burning Rock
- Cactus Semiconductor
- Cadila Pharmaceuticals
- California Institute for Biomedical Research
- Cambrooke Therapeutics
- Can-Fite BioPharma
- Cancer Genetics
- CannaSoul Analytics
- Cannassure Therapeutics
- Canon BioMedical
- Capsida Biotherapeutics
- Captor Therapeutics
- Caraway Therapeutics
- CARB-X
- Carbios
- CardieX
- Cardiff University
- CardioFocus
- Cardiovascular Systems
- Carina Biotech
- Caring Cross
- Caris Life Sciences
- Carl Zeiss
- Carl Zeiss Meditec
- Cartesian Therapeutics
- Catalent
- CBT Pharmaceuticals
- CEA-Leti
- Cedars-Sinai Medical Center
- Celgene
- Cellares
- Cellastra
- CellCarta
- Cellgen Diagnostics
- Cellino Biotech
- Cellipont Bioservices
- CellPoint
- Celltrion
- Cellular Biomedicine
- Cellular Origins
- Cellvera
- Censa Pharmaceuticals
- Center for Sensorimotor Neural Engineering
- Centers for Disease Control and Prevention
- Central Institute for Experimental Animals
- Centre for Commercialization of Regenerative Medicine (CCRM)
- Cepheid
- Cerenis Therapeutics
- Cerulean Pharma
- Champions Oncology
- Charles River Laboratories
- Cheil Pharm
- ChemDiv
- Chemical Abstracts Service (CAS)
- Chi-Med
- Chiesi Global Rare Diseases
- Chime Biologics
- China Medical System
- China National Biotech Group (CNBG)
- China Resources Sanjiu Medical and Pharmaceutical
- Chinese Academy of Sciences
- Chiome Bioscience
- ChroMedX
- CicloMed
- Cidara Therapeutics
- CimCure
- Cipla
- Ciron Drugs & Pharmaceuticals
- ClearPoint Neuro
- Cleveland Clinic
- Clinical Study Support
- Closed Loop Medicine
- CMDC Labs
- CN Bio
- Coave Therapeutics
- Codagenix
- Coeptis Pharmaceuticals
- Coherus Biosciences
- Collplant
- Complement Pharma
- Complete Genomics
- Conductive Technologies
- Conduit Pharmaceuticals
- Confo Therapeutics
- Context Therapeutics
- Contineum Therapeutics
- Cosmo Pharmaceuticals
- Covestro
- Crescent Biopharma
- CRISPR Therapeutics
- CrystalGenomics
- CSL
- CStone Pharmaceuticals
- CtM Biotech
- Cue Biopharma
- Cullgen
- Cullinan Oncology
- Culture Biosciences
- CURE Pharmaceutical
- CureVac
- Curi Bio
- Curium
- CutisPharma
- Cyagen Biosciences
- Cygnus
- CytomX Therapeutics
- Cytovance Biologics
- Dabur
- Daewoong Pharmaceutical
- Daiichi Sankyo
- Dana-Farber Cancer Institute
- Dance Biopharm
- Dare Bioscience
- DaRui Biotech
- Databricks
- Datavant
- Debiopharm
- Deciphex
- DeepHealth
- Definiens
- Denali Therapeutics
- Densitas
- Department of Defence
- Department of Defense
- Department of Health and Human Services
- DePuy
- Dermata Therapeutics
- Dermavant Sciences
- DeRoyal
- Diabeloop
- Dicerna Pharmaceuticals
- DigiLab
- Discovery Life Sciences
- Dizlin Pharmaceuticals
- Donaldson Company
- DotBio
- Dotmatics
- Dow AgroFresh
- Dr. Falk Pharma
- Dr. Reddy's Laboratories
- Dropshot Therapeutics
- Drug Farm
- Dryworld
- DSM
- DualityBio
- Duke-NUS Graduate Medical School Singapore
- Duke University
- Duoning Biotechnology
- DxVx
- Dyadic International
- eCential Robotics
- Edan Instruments
- EdgeEndo
- Editas Medicine
- eGenesis
- Eikon Therapeutics
- EirGenix
- Eisai
- Eko Health
- Elekta
- Elektrofi
- Element Biosciences
- ElevateBio
- EligoChem
- Eli Lilly
- Elite Pharmaceuticals
- Elpis Biomed
- Emergent BioSolutions
- EmeritusDX
- Emmaus Life Sciences
- Empa
- Empirico
- Enable Injections
- Energenesis Biomedical
- Energesis Pharmaceuticals
- Enigma Biomedical
- Enko
- Enlaza Therapeutics
- Ensysce Biosciences
- Entasis Therapeutics
- Entera Bio
- Enterome Bioscience
- EpimAb Biotherapeutics
- EpiVax Therapeutics
- Escugen
- Especificos Stendhal
- EspeRare Foundation
- Esperovax
- Essex Bio-Technology
- Estee Lauder
- eTheRNA immunotherapies
- Ethris
- Eurofarma
- Evercyte
- Evidation Health
- Evidera
- Evonetix
- Evonik Industries
- Evosep
- Evotec
- EVQLV
- Evvivax
- Exactech
- Exact Sciences
- Excelra
- Exosome
- ExPLoRNA Therapeutics
- Eybna Technologies
- Eyegene
- Eyenovia
- Fabric Genomics
- FairJourney Biologics
- Fannin
- Farmacore Biotechnology
- Fate Therapeutics
- Fermbox Bio
- Ferrer
- Ferrer International
- FineImmune Biotechnology
- Firebrand Therapeutics
- Flightpath Biosciences
- Flowerkist
- FlowJo
- fluidIQ
- Foghorn Therapeutics
- FogPharma
- Foresee Pharmaceuticals
- Foresight Diagnostics
- Formation Bio
- Form Bio
- Formosa Pharmaceuticals
- Forsyth Institute
- Fosun Pharmaceutical
- Foundation Medicine
- Fraunhofer Institute for Cell Therapy and Immunology
- Fresenius Kabi Pharmaceuticals
- Frontier Medicines
- Fulcrum Therapeutics
- Fusion Pharmaceuticals
- Fuzionaire Radioisotope Technologies
- FYR Diagnostics
- G2 Speech
- Galapagos
- Galderma
- GATC Health
- GB Sciences
- Gedeon Richter
- GE Healthcare
- Genentech
- GeneQuantum Healthcare
- Generate Biomedicines
- Genethon
- Genetic Analysis
- Genetic Signatures
- Genevant Sciences
- Genialis
- Geninus
- Genmab
- Genome Institute of Singapore
- Genomic Testing Cooperative
- Genomind
- Genoptix
- Genosity
- GenScript Biotech
- GensKey Medical Technology
- Genzyme
- Georgia State University Research Foundation (GSURF)
- Getein Biotech
- Gicell
- GigaMune
- Gilead Sciences
- Ginkgo BioWorks
- Glatt Group
- Glimpse Group
- Global Access Diagnostics
- Global Antibiotic Research and Development Partnership
- Global Dx
- Global Health Labs
- GlycoNex
- Glytherix
- GMSbiotech
- GoodRx
- GPCR Therapeutics
- Great Bay Bio
- Greenlight Biosciences
- GRIT Biotechnology
- GSK
- GTEC Holdings
- Guangzhou Boji Medical Biotechnological
- Guardant Health
- Guerbet
- H.M. Pharma Consultancy
- H3 Biomedicine
- HalioDx
- HaloVax
- Halozyme Therapeutics
- Hamamatsu Photonics
- Hamlet Pharma
- HanAll Pharmaceuticals
- HanchorBio
- Hanmi Pharmaceutical
- Happify Health
- Harbour Antibodies
- Harbour Biomed
- Harvard University
- HCW Biologics
- HDT Bio
- HealthTrackRx
- HeartBeam
- Heartflow
- HebeCell
- HEC Pharm
- Helix
- HELP Therapeutics
- Helsinn Healthcare
- Helsinn Therapeutics
- Hemispherian
- Henlius Biotech
- HiberCell
- HiFiBio
- High Beauty
- Hikma Pharmaceuticals
- Histogen
- Hitachi Chemical
- HK inno.N
- HMNC Brain Health
- Hollister Biosciences
- Horizon Discovery
- Hoth Therapeutics
- HTC ChemRar
- Huadong Medicine
- Huami
- Hufeland Klinikum
- Humacyte
- Hummingbird Bioscience
- Hydrix Services
- Hygtia Therapeutics
- Hyloris Pharmaceuticals
- Hypertrust
- Hypospray Pharma
- I-Dante
- I-mab
- i2c Pharmaceutical Services
- IACTA Pharmaceuticals
- Iambic Therapeutics
- IBA
- iBio
- IBM Watson Health
- iCAD
- Icagen
- IDbyDNA
- IDEAYA Biosciences
- Idorsia
- Igentify
- Iktos
- Illumina
- Imagene Labs
- IMBdx
- Immatics Biotechnologies
- ImmBio
- ImmunityBio
- Immunocore
- Immunovia
- IMMvention Therapeutix
- IMPACT Therapeutics
- Imperial College London
- Implant Surfaces
- Impression Healthcare
- Imricor Medical Systems
- Imugene
- Inceptor Bio
- Incyte
- Indivumed
- InduPro Therapeutics
- Infervision
- Infex Therapeutics
- InflaRx
- Innate Pharma
- inno-train Diagnostik
- Innosuisse
- Innovent Biologics
- Inocras
- Inova Genomics Laboratory
- Inovio Pharmaceuticals
- Insilico Medicine
- Insitro
- InSitu Biologics
- Inspirna
- Institute of Microchemical Technology
- Institut Gustave Roussy
- Institut Pasteur
- Intabio
- Integrated Cannabis Company
- Integrated DNA Technologies
- IntelGenx
- Intellia Therapeutics
- Intelligent Scopes
- International Flavors and Fragrances
- Intravacc
- Intuitive Surgical
- InventisBio
- Invetx
- inviCRO
- Ionis Pharmaceuticals
- iPharma
- Ipsen
- IQVIA
- IRLAB
- Ironwood Pharmaceuticals
- iTeos Therapeutics
- ITM Isotopen Technologien
- iTolerance
- Iwatani Group
- Ix Therapeutics
- Jabez Pharma
- Jacobio Pharma
- Jacobio Pharmaceuticals
- Janssen Biotech
- Janssen Pharmaceuticals
- Janssen Pharmaceutica NV
- Janssen Research & Development
- Janux Therapeutics
- Japan Tobacco
- JCR Pharmaceuticals
- Jeffrey Modell Foundation
- JelloX Biotech
- JETA Molecular
- Jiangsu Carephar Pharmaceutical
- Jiangsu Hengrui Medicine
- Jiangsu NHWA Pharmaceutical
- Jiangxi Kvvit Pharmaceutical
- Johns Hopkins University
- Johnson & Johnson Innovation
- JSR
- Junshi Biosciences
- Juntendo University
- JustRight Surgical
- JW Therapeutics
- Kadimastem
- Kaiku Health
- Kainos Medicines
- Kaken Pharmaceutical
- Kalos Therapeutics
- Kanabo Research
- Karis Bio
- Karl Storz
- Kartos Therapeutics
- Kelun-Biotech Biopharmaceutical
- KilgourMD
- Kissei Pharmaceutical
- Kite Pharma
- Klaria
- Kleo Pharmaceuticals
- KSQ Therapeutics
- KT Corporation
- Kudo Biotechnology
- Kura Oncology
- Kymanox
- Kyorin Pharmaceutical
- Kyowa Hakko Kirin
- Kyverna Therapeutics
- L7 Informatics
- LabGenius Therapeutics
- Laboratoires Thea
- Laboratorios Ordesa
- Laekna
- Lannett
- Lantheus Holding
- Launch Therapeutics
- LaunXP Biomedical
- Laxai Pharma
- Lead Discovery Center
- Legend Biotech
- LegoChem Biosciences
- Leica Biosystems
- LenioBio
- Leon-nanodrugs
- LEO Pharma
- Les Laboratoires Servier
- Leucid Bio
- Leukemia & Lymphoma Society
- Leveragen
- Lexitas Pharma Services
- LG Chem
- LG Life Sciences
- LianBio
- LifeLabs Medical Laboratory Services
- LifeLink Foundation
- LifeLiver
- Life Magnetics
- LifeQ
- Life Technologies Corporation
- Likarda
- LineaRx
- Lipidor
- Lipigon Pharmaceuticals
- Liquid Biosciences
- Lisata Therapeutics
- Livzon Pharmaceutical
- LogicNets
- Lonza
- Louisiana State University
- Loxo Oncology
- LTS Lohmann Therapie-Systeme
- Lumen Biomedical
- Lundbeck
- Lunit
- Luye Pharma Group
- Lyell Immunopharma
- Lygos
- Lynk Pharmaceuticals
- Macrogen
- MagForce
- Magic Leap
- MAIA Pharmaceuticals
- mAIbe
- Mainz Biomed
- Makana Therapeutics
- MAKScientific
- MangoGen Pharma
- Manifold AI
- Manoira Corporation
- Marizyme
- MASORI Therapeutic
- Massachusetts General Hospital
- MaSTherCell
- Matchpoint Therapeutics
- Max-Delbruck Center for Molecular Medicine
- Maxcyte
- Maya Medical
- Mayo Clinic
- Mazor Robotics
- McQuade Center for Strategic Research and Development
- MD Anderson Cancer Center
- Meatable
- Mechelen
- Medicines Discovery Catapult
- MediciNova
- Medicover
- Medicovestor
- Medidata Solutions
- Medigen Biotechnology
- MediGene
- Medigen Vaccine Biologics
- MediLink Therapeutics
- MedImmune
- MedinCell
- Medipal Holdings
- Medis Medical Imaging
- Medline
- Medocann Pharma
- Medolife Rx
- Medtronic
- Medx
- Medytox
- Meihua International Medical Technologies
- MEI Pharma
- Mekonos
- Melinta Therapeutics
- MeMed
- Memorial Sloan Kettering Cancer Center
- Menarini
- Mercachem
- Merck and Co
- Merck KGaA
- Merdury Biopharmaceutical
- Meridian Laboratories
- Mersana Therapeutics
- Merus
- Merz
- Merz Therapeutics
- Mesoblast
- Metabolon
- Metagenomi
- Metalabs
- MetP Pharma
- MGI Pharma
- MGI Tech
- Microbiotix
- Microsoft
- Mie University
- MiLaboratories
- Millennium
- MilliporeSigma
- Miltenyi Biotec
- Mirati Therapeutics
- MiRTLE Medical
- Mission Bio
- Mission Health
- Mobility Health
- Mobvoi
- Mochida Pharmaceutical
- Moderna
- Molecular Instruments
- Molecular Partners
- Molecular Templates
- Molecule.one
- Molnlycke Health Care
- Mologen
- Momenta Pharmaceuticals
- Monte Rosa Therapeutics
- Moonlight Bio
- Morphic Therapeutic
- MorphoSys
- Mount Sinai Medical Center
- MRI Interventions
- MSD Wellcome Trust Hilleman Laboratories
- MultiOmic Health
- Multiplex Genomics
- Multispan
- Mundipharma
- Mundo Sano
- Mydecine Group
- MYOS
- Myriad Genetics
- N1 Life
- Nalagenetics
- NAMSA
- Nanion
- Nankai Hospital
- Nanobiotix
- Nanoform
- Nanomix
- Nanommune
- NanoSmart Pharmaceuticals
- NanoString Technologies
- NantKwest
- Nascent Biotech
- NATA
- Natera
- National Cancer Institute
- National Healthcare Services (NHS)
- National Immunobiological Company
- National Institutes of Health
- Navitor Pharmaceuticals
- Ncardia
- NEC
- NEC Bio Therapeutics
- Nektar Therapeutics
- Neo Gene Pharm
- Neo Medical
- Neomorph
- Neptune Technologies & Bioressources
- Neptune Wellness Solutions
- NeraCare
- Nestle Health Science
- Neuracle Genetics
- Neuraly
- Neuraxpharm
- Neuro3 Therapeutics
- Neurochase
- Neurocrine Biosciences
- Neurophth Therapeutics
- NeuroSigma
- New England Biolabs
- Newly Institute
- Newsoara Biopharma
- NextCure
- Next Gen Diagnostics
- Next Generation Manufacturing Canada
- NFL Biosciences
- NGK Spark PLug
- Nihon Nohyaku
- Nikon Instruments
- Nippon Kayaku
- Nipro Corporation
- Nivagen Pharmaceuticals
- Nkarta Therapeutics
- Noile-Immune Biotech
- Nona Biosciences
- Noramco
- Northern RNA
- Norwegian University of Science
- Notable Labs
- NOTA Laboratories
- Novartis
- Novavax
- Novel351k
- NovImmune
- Novogene
- Novoheart
- Novo Nordisk
- Novosound
- Novozymes
- Nuance Pharma
- Numab
- NuProbe
- Nurix Therapeutics
- NurrOn Pharmaceuticals
- NutriQuest
- Nuvalent
- NuVasive
- Nvidia
- nView Medical
- O2nix Bio
- Ocean Genomics
- Oceanus Bio
- Ocugen
- Ocumension Therapeutics
- Ohio State University
- Olema Oncology
- Olympus
- OMass Therapeutics
- OmniaBio
- OMNY Health
- OncoC4
- Oncologie
- Oncology Pharma
- Oncology Venture
- Oncozen
- OncoZenge
- One BioMed
- OneMedNet
- OnFace
- ONK Therapeutics
- Ono Pharmaceutical
- Ontada
- Onward Therapeutics
- OpenAI
- Open Book Extracts
- Opentrons Labworks
- OPKO Health
- Optimi Health
- Optum
- Orano Med
- Ordaos Bio
- Oregon Health Sciences University
- Orexo
- OrganOx
- Orgenesis
- Ori Biotech
- Orient Pharma
- Orion
- Orizuru Therapeutics
- Orlando Health
- Orpheus Medical
- Orthofix Medical
- Osaka University
- OSE Immunotherapeutics
- Oswaldo Cruz Foundation (Fiocruz)
- Otsuka
- Ouro Medicines
- Oxford BioMedica
- Oxford Nanopore Technologies
- Oxis International
- P-Chip
- Pacific Biosciences
- PACT Pharma
- Paige
- Pairnomix
- Palisade Bio
- Pall Corporation
- Panaxium
- Partex Group
- Pasithea Therapeutics
- PathAI
- Pathalys Pharma
- PathGroup
- Pathos AI
- Paul Scherrer Institute
- PAVmed
- PDS Biotechnology
- Pebble Labs
- PeptiDream
- PeptiGrowth
- Perlara
- Persist AI
- Personal Genome Diagnostics
- Pfizer
- Phanes Therapeutics
- Pharmanovia
- Pharmaron
- Pharmathen
- PharmaTher
- PhaseBio Pharmaceuticals
- PHC
- Phillips-Medisize
- Phlow
- PhoreMost
- Photocure ASA
- Phrontline Biopharma
- Phylloceuticals
- Pieris Pharmaceuticals
- Pierre Fabre
- PlantArcBio
- Pleco Therapeutics
- Plexium
- Pluristyx
- PMV Pharma
- PolyPeptide Group
- Polyphor
- Portal Bioscience
- Praj Industries
- Precise Biometrics
- Precisio Biotix Therapeutics
- PrecisionLife
- Precision NanoSystems
- Precision NeuroMed
- Precision Neuroscience
- Predicine
- Prellis Biologics
- Premier Inc
- Prestige BioPharma
- Prevail Therapeutics
- PreventionGenetics
- Prilenia Therapeutics
- Primrose Bio
- PRISM BioLab
- ProBioGen
- Procare Health
- ProGen Co
- Project to Accelerate New Treatments for Tuberculosis
- Proliant Health and Biologicals
- Promega
- Promethera Biosciences
- Prometheus Biosciences
- Promore Pharma
- Propeller Health
- Proprio
- Protagonist Therapeutics
- Protalix BioTherapeutics
- Protea Biosciences
- Protein Metrics
- Protein Sciences
- ProteinTech
- ProteoMediX
- Proteovant Therapeutics
- Provention Bio
- Psyence Biomedical
- Pulmatrix
- Pulmodyne
- Purdue Pharma
- Purdue University
- Pure Extracts Technologies
- Pure Protein
- QED Therapeutics
- QIAGEN
- Qilu Pharmaceutical
- Quadira Biosciences
- Qualcomm
- Qualigen
- Quantum-Si
- Quark Pharmaceuticals
- Quell Therapeutics
- Quratis
- Rad AI
- Radiomedix
- Radiopharm Theranostics
- RadNet
- Rainbow Medical
- Rakovina Therapeutics
- Rakuten Medical
- Rambam Medical Center
- Ramot at Tel Aviv University
- Rani Therapeutics
- Re-Vana Therapeutics
- Rebus Biosystems
- RedHill Biopharma
- Redlen Technologies
- RefleXion Medical
- Refuge Biotechnologies
- Regen BioPharma
- Regeneron Pharmaceuticals
- RemeGen
- Rennovia
- Renovaro BioSciences
- Repado
- Repair Biotechnologies
- Repare Therapeutics
- Repertoire Immune Medicines
- Replicel Life Sciences
- Research Council of Norway
- Resolve Biosciences
- RespireRx Pharmaceuticals
- Retrophin
- Revance Therapeutics
- ReveraGen BioPharma
- Revolution Medicines
- Revvity
- Reyon Pharmaceuticals
- Rgene
- Richard Wolf Medical Instruments
- Rigel Pharmaceuticals
- RightEye
- Roche
- Roche Diagnostics
- Rocket VR Health
- Roivant Sciences
- Roncadelle Operations
- RoosterBio
- Rosalind
- Rouumtech
- Royal GD
- Royal Philips Electronics
- Rznomics
- Sajo Consulting
- Salus Pharma
- Samsung Bioepis
- Samsung Biologics
- SanBio
- Sandoz
- SanegeneBio
- Sanford Health
- Sanofi
- Santen Pharmaceutical
- Sanyou Biopharmaceuticals
- Sarah Cannon Research Institute
- Sarepta Therapeutics
- Sartorius
- SATT Nord
- SATT Paris-Saclay
- SBRI Healthcare
- Scandinavian Health
- Scandion Oncology
- Schrodinger
- SciClone Pharmaceuticals
- Scienion
- Scipher Medicine
- Scivita Medical Technology
- SCM Pharma
- Scorpion Therapeutics
- Scottish Enterprise
- Scribe Therapeutics
- Seagen
- Seattle Genetics
- Secarna Pharmaceuticals
- Seikagaku
- Seipasa
- Selvita
- Semtech
- Sen-Jam Pharmaceutical
- Senai Cimatec
- Sensifree
- Sensorion
- Sentieon
- Sentinel Oncology
- Sequel Med Tech
- SequMed
- SeqWell
- Seracare Life Sciences
- Serum Institute of India
- SFJ Pharmaceuticals
- SGN Nanopharma
- Shandong Boan Biological Technology
- Shandong Luoxin Pharma
- Shanghai Ark Biopharmaceutical
- Shanghai Institute of Materia Medica
- Sharps Technology
- Sheba Medical Center
- Shilpa Medicare
- Shimadzu
- Shionogi
- Shuwen Biotech
- Siemens Healthineers
- Silexion Therapeutics
- Silo Pharma
- SimBioSys
- Simcere Pharmaceutical
- Simcere Zaiming
- Similis Bio
- Simulations Plus
- Sinergium Biotech
- Sino Biological
- SINTX Technologies
- Sirenas
- Siren Biotechnology
- Sirius Therapeutics
- Sirnaomics
- SiSaf
- SK Biopharmaceuticals
- SK Bioscience
- SK Pharmteco
- Skye Bioscience
- Skyline Diagnostics
- SkylineDX
- Smartwise
- SN BioScience
- Sofregen Medical
- Soitec
- Solesis
- Solid Biosciences
- SomaLogic
- Sonova
- Sony
- Sorrento Therapeutics
- Sosei
- Soufflé Therapeutics
- Sovargen
- Spectrum Pharmaceuticals
- Spencer Health Solutions
- Spineart
- Spruce Biosciences
- STADA Arzneimittel
- Staidson (Beijing) BioPharmaceuticals
- Statera Spine
- Stealth BioTherapeutics
- StemCardia
- Stemmatters
- StemoniX
- Stempeutics
- Stereotaxis
- SteriLumen
- Stockton Group
- Stoke Therapeutics
- Stora Enso
- Storm ID
- StrideBio
- Striiv
- Sublime Stericeuticals
- SUDA Pharmaceuticals
- Sumitomo Dainippon Pharma
- Summit Pharmaceuticals
- SunGen
- Sunny Pharmtech
- Sunovion Pharmaceuticals
- SunRock Biopharma
- Supernus Pharmaceuticals
- SurgiBox
- Sutro Biopharma
- Sutter Health
- Swedish Bactiguard
- Swedish Orphan Biovitrum
- Symbasis
- Synaptive Medical
- SynCardia Systems
- Synchronous Health
- SynerK
- Synfini
- Syngenta
- Synpromics
- SynShark
- SyntheticMR
- Sysmex
- Tachyon Therapeutics
- Tactical Relief
- Taiho
- TaiwanBio Therapeutics
- TaiwanJ Pharmaceuticals
- Taiwan Tanabe Seiyaku
- Takeda Pharmaceutical
- Takis Biotech
- TALLC
- Tangible Science
- Tango Therapeutics
- Tarveda Therapeutics
- Tavotek Biotherapeutics
- TC BioPharm
- Tecan
- Techsomed
- Teijin
- Telix Pharmaceuticals
- Tempus
- TeraRecon
- Terumo
- Tessellate Bio
- Tessera Therapeutics
- Tetra Bio-Pharma
- Teva Pharmaceutical Industries
- Texas A&M University
- TFF Pharmaceuticals
- TG Therapeutics
- The Jackson Laboratory
- The Nutraceutical Medicine Company
- Theramex
- Therapyx
- Theravance
- Therawis Diagnostics
- Therma Bright
- Thermo Fisher Scientific
- ThinkCyte
- Tianjin CanSino Biotechnology
- Tilray
- Tissue Analytics
- Tobii Technology
- TOMA Biosciences
- TONIX Pharmaceuticals
- Toolgen
- Torii Pharmaceutical
- Torrey Pines Investment
- Tracer Biotechnologies
- Transcenta
- TransCode Therapeutics
- Transgene
- Translational Software
- Transplant Genomics
- Treventis
- Trinity Biotech
- Triplebar Bio
- Triple Ring Technologies
- TrovaGene
- Trovita Health Science
- TRPharm
- TSRL
- Turnstone Biologics
- Twist Bioscience
- TYG Oncology
- UbiQ
- Ubiquigent
- UCB
- UGISense
- Ultivue
- Ultragenyx Pharmaceuticals
- Umami Meats
- Undisclosed Company
- Uni-Bio Science
- United Therapeutics
- Univercells
- Universal Cells
- University Hospital of Leuven
- University of Amsterdam
- University of Bonn
- University of Buffalo
- University of California
- San Diego
- University of Copenhagen
- University of Glasgow
- University of Heidelberg
- University of Massachusetts Medical School
- University of North Texas
- University of Ottawa
- University of Surrey
- Univo Pharmaceuticals
- Us2.ai
- Vaccitech
- Valent Biosciences
- Validogen
- VALID Therapeutics
- Valneva
- Valo Health
- Variational AI
- Vasomune Therapeutics
- Vaximm
- Vaxine
- Vaxxas
- VeChain
- Vect-Horus
- VectorBuilder
- Velabs Therapeutics
- VenatoRx
- Ventana Medical Systems
- Veranome Biosystems
- Verastem
- Veravas
- Veraxa Biotech
- Verge Genomics
- Verily
- Vertex Pharmaceuticals
- ViaCyte
- Vical
- Vici Health Sciences
- Vifor-Fresenius Medical Care Renal Pharma
- Virbac
- Vir Biotechnology
- Virginia Tech
- Viridian Therapeutics
- Visiopharm
- Visualant
- Vium
- vivoPharm
- Vizgen
- Volta Labs
- Volta Medical
- Voltron Therapeutics
- Voluntis
- Voyager Therapeutics
- VSP Optics
- Vyant Bio
- VyGen-Bio
- Wanchunbulin
- Wasatch BioLabs
- Watchmaker Genomics
- WAVE Life Sciences
- Weill Cornell Medical College
- WellDoc
- Wellmarker Bio
- WestGene Biopharma
- Westlake Pharma
- Willow Biosciences
- W L Gore
- WuXi Biologics
- WuXi XDC
- WY Biotech
- Wyss Institute
- X4 Pharmaceuticals
- Xbiome
- Xbrane Biopharma
- Xcell Biosciences
- Xencor
- Xenon Pharmaceuticals
- XERIS Pharmaceuticals
- Xiamen Amoytop Biotech
- Xortx Therapeutics
- Xylonix
- Yabao Pharmaceutical
- Yamaha Motor
- Yatiri Bio
- Yingli Pharma
- Yisheng Biopharma
- YOFOTO (China) Health Industry
- Yonsei University Severance Hospital
- Yuhan Corporation
- Yunnan Walvax Biotech
- YVY Life Sciences
- Zai Lab
- ZAI Laboratory
- Zealand Pharma
- Zebra Medical Vision
- Zephyr AI
- Zepp Health
- Zivo Bioscience
- Zydus Cadila
- Zylo Therapeutics
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...
